Evaluation of prognostic utility of MIB-1 and p53 expression in pituitary adenomas: correlations with clinical behaviour and follow-up results

Asen HadzhiyanevDepartment of Neurosurgery, University Hospital ‘St. Ivan Rilsky’, Medical University of Sofia, Sofia, BulgariaCorrespondence[email protected]

Radina IvanovaClinical Center of Endocrinology and Gerontology, Medical University of Sofia, Sofia, Bulgaria

Emil NachevClinical Center of Endocrinology and Gerontology, Medical University of Sofia, Sofia, Bulgaria

Atanaska ElenkovaClinical Center of Endocrinology and Gerontology, Medical University of Sofia, Sofia, Bulgaria

Maria YanevaClinical Center of Endocrinology and Gerontology, Medical University of Sofia, Sofia, Bulgaria

Sabina ZaharievaClinical Center of Endocrinology and Gerontology, Medical University of Sofia, Sofia, Bulgaria

Marin MarinovDepartment of Neurosurgery, University Hospital ‘St. Ivan Rilsky’, Medical University of Sofia, Sofia, Bulgaria

Jivko SurchevDepartment of Neurosurgery, University Hospital ‘St. Ivan Rilsky’, Medical University of Sofia, Sofia, Bulgaria

Asya IvanovaMedical University of Sofia, Sofia, Bulgaria

show all

Evaluation of prognostic utility of MIB-1 and p53 expression in pituitary adenomas: correlations with clinical behaviour and follow-up results

Articles from other publishers (9)

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Evaluation of prognostic utility of MIB-1 and p53 expression in pituitary adenomas: correlations with clinical behaviour and follow-up results

Citations (9)

Articles from other publishers (9)

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date